Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07443670 · ClinicalTrials.gov registry record
Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure
A clinical trial of Heart Failure, sponsored by Noah Labs.
- Recruiting
- Registry status
- 60
- Enrollment target
- 3
- Study locations
NCT07443670: Recruiting study of Heart Failure, sponsored by Noah Labs.
NCT07443670 is a study of Heart Failure that is actively recruiting participants, run by Noah Labs. The registered enrollment target is 60 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07443670, a study of Heart Failure, is actively recruiting participants, sponsored by Noah Labs.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
VAPP-HF is a prospective, multi-center, observational study assessing whether daily voice recordings analyzed by a machine learning algorithm can detect changes in pulmonary arterial (PA) pressure in heart failure patients with implanted PA pressure sensors (e.g., CardioMEMS, Cordella). Patients across three sites in Germany and the United States provide daily voice recordings via a mobile app for 12 weeks while continuing standard PA pressure monitoring and heart failure care. Voice data is analyzed retrospectively after study completion; no clinical decisions are based on voice analysis during the study. The primary endpoint is the sensitivity and specificity of the AI-based voice analysis in detecting PA pressure changes at defined thresholds.
Conditions Studied
Interventions
- OTHER Daily Voice Recording
Study Locations (3)
California
- University of California, San Francisco (UCSF) - San Francisco
State of Berlin
- BG Klinikum Unfallkrankenhaus Berlin, Dept. of Cardiology - Berlin
Other
- University Hospital Frankfurt, Dept. of Cardiology and Angiology - Frankfurt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-12-12 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07443670
The ClinicalTrials.gov registry entry for NCT07443670 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is Noah Labs, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Daily Voice Recording is the first listed.
NCT07443670 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, State of Berlin, Other.
Frequently Asked Questions
What is clinical trial NCT07443670 about?
NCT07443670 is a clinical study titled "Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure". VAPP-HF is a prospective, multi-center, observational study assessing whether daily voice recordings analyzed by a machine learning algorithm can detect changes in pulmonary arterial (PA) pressure in heart failure patients with implanted PA pressure sensors (e.g., CardioMEMS, Cordella). Patients acr...
What is the current status of trial NCT07443670?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2024-12-12. Estimated completion is 2026-09.
What conditions does trial NCT07443670 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT07443670?
The interventions under investigation include: Daily Voice Recording (OTHER).
Who is sponsoring clinical trial NCT07443670?
This trial is sponsored by Noah Labs, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07443670 being conducted?
This trial has 3 study locations across California, State of Berlin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.